Javier Alegre‐Abarrategui
- Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 18
- Neurological disorders and treatments 9
- Amyotrophic Lateral Sclerosis Research 4
- Neurological diseases and metabolism 3
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 18
- Neurological disorders and treatments 9
- Amyotrophic Lateral Sclerosis Research 4
- Neurological diseases and metabolism 3
-
- Genetic Neurodegenerative Diseases 3
- Physiology top 2%
- Alzheimer's disease research and treatments 6
- Cell Biology top 5%
-
- Autophagy in Disease and Therapy 4
-
- Neurogenetic and Muscular Disorders Research 3
- Co-authors
- Richard Wade‐MartinsRosalind F. RobertsIsrael AmpueroJusto Garcı́a de YébenesRaquel RosDavid G. MuñozJanet HoenickaJuan Carlos Gómez‐Esteban
- Partner nations
- United KingdomCanadaSpain
In The Last Decade
Javier Alegre‐Abarrategui
25 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Neurology 3.0k
- Neurology 708
- Cellular and Molecular Neuroscience 1.4k
- Physiology 1.3k
- Cell Biology 421
Countries citing papers authored by Javier Alegre‐Abarrategui
This map shows the geographic impact of Javier Alegre‐Abarrategui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Alegre‐Abarrategui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Alegre‐Abarrategui more than expected).
Fields of papers citing papers by Javier Alegre‐Abarrategui
This network shows the impact of papers produced by Javier Alegre‐Abarrategui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Alegre‐Abarrategui. The network helps show where Javier Alegre‐Abarrategui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Javier Alegre‐Abarrategui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2021 | 24 | |
| 4 | 2020 | 187 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 57 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 66 | |
| 9 | 2017 | 266 | |
| 10 | 2016 | 56 | |
| 11 | 2015 | 201 | |
| 12 | 2014 | 0 | |
| 13 | 2014 | 44 | |
| 14 | 2013 | 60 | |
| 15 | 2013 | 18 | |
| 16 | 2012 | 118 | |
| 17 | 2009 | 357 | |
| 18 | 2009 | 44 | |
| 19 | 2007 | 61 | |
| 20 | The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiabreakdown → | 2003 | 2133 |
About Javier Alegre‐Abarrategui
Javier Alegre‐Abarrategui is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 3.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers), Alzheimer's disease research and treatments (6 papers), Amyotrophic Lateral Sclerosis Research (4 papers), Autophagy in Disease and Therapy (4 papers), Neurological diseases and metabolism (3 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Genetic Neurodegenerative Diseases (3 papers). The work is most often cited by research in Neurology (3.0k citations), Neurology (708 citations) and Cellular and Molecular Neuroscience (1.4k citations). Javier Alegre‐Abarrategui has collaborated with scholars based in United Kingdom, Canada and Spain. Frequent co-authors include Richard Wade‐Martins, Rosalind F. Roberts, Israel Ampuero, Justo Garcı́a de Yébenes, Raquel Ros, David G. Muñoz, Janet Hoenicka, Juan Carlos Gómez‐Esteban, Olga Rodriguez and Elena Lezcano. Their work appears in journals such as Nature Communications, Brain and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.